Skip to main content
. 2018 Mar 6;35(1):27–34. doi: 10.4274/tjh.2017.0021

Figure 5. Survival of patients according to PTPN11 mutation status in patients for whom JMML mutation analysis was conducted (n=32) (PTPN11 mutation: n=9, NRAS/KRAS/CBL/no mutation: n=23).

Figure 5